Keyword: pharma

Agreement for Biosimilar Candidates in Key Central and Eastern European Markets

• mAbxience and Egis collaborate on the commercialization of two biosimilar candidates • The agreement covers eight Central and Eastern European countries with the potential for expansion into additional territories • mAbxience will serve as the marketing authorization holder, while Egis will manage commercialization in the designated regions

More

Csaba Poroszlai elected vice president of MAGYOSZ

Mr. Csaba Poroszlai, CEO of Egis and dr Tamás Rónay CEO of Sanofi-Aventis and Chinoin were elected vice presidents of the Hungarian Pharmaceutical Manufacturers’ Association (MAGYOSZ) at the Association’s annual general meeting. The executive director of Meditop Kft., dr Dávid Greskovits, will hold the position of president for another three years. Mr. Csaba Poroszlai has also become the member of the presidential board.

More

Discover the Hungarian Medicine brand

It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can lead a long and healthy life.

More

Pharmaceutical industry is one of the key players of the Hungarian economy

The performance of the Hungarian pharmaceutical industry in the last ‘peaceful year’ before the coronavirus epidemic was reviewed in a comprehensive analysis by Nézőpont Institute on behalf of 16 pharmaceutical companies of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ).

More
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox